vs
Side-by-side financial comparison of CapsoVision, Inc (CV) and Identiv, Inc. (INVE). Click either name above to swap in a different company.
Identiv, Inc. is the larger business by last-quarter revenue ($6.2M vs $3.5M, roughly 1.7× CapsoVision, Inc). Identiv, Inc. runs the higher net margin — -60.3% vs -223.9%, a 163.5% gap on every dollar of revenue. Identiv, Inc. produced more free cash flow last quarter ($2.8M vs $-5.7M).
CapsoVision, Inc. is a medical technology firm specializing in the development and manufacturing of advanced capsule endoscopy systems and supporting diagnostic solutions. Its non-invasive gastrointestinal imaging products are supplied to hospitals, gastroenterology clinics and medical specialists across global markets, supporting more accurate detection of digestive diseases and improved patient care experiences.
Identiv is a publicly traded Internet of Things technology company listed on the Nasdaq stock market.
CV vs INVE — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.5M | $6.2M |
| Net Profit | $-7.9M | $-3.7M |
| Gross Margin | 54.1% | 18.1% |
| Operating Margin | -226.7% | -76.4% |
| Net Margin | -223.9% | -60.3% |
| Revenue YoY | — | -7.9% |
| Net Profit YoY | — | -948.2% |
| EPS (diluted) | $-0.17 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $6.2M | ||
| Q3 25 | $3.5M | $5.0M | ||
| Q2 25 | $3.3M | $5.0M | ||
| Q1 25 | — | $5.3M | ||
| Q4 24 | — | $6.7M | ||
| Q3 24 | — | $6.5M | ||
| Q2 24 | — | $6.7M | ||
| Q1 24 | — | $6.7M |
| Q4 25 | — | $-3.7M | ||
| Q3 25 | $-7.9M | $-3.5M | ||
| Q2 25 | $-4.6M | $-6.0M | ||
| Q1 25 | — | $-4.8M | ||
| Q4 24 | — | $-355.0K | ||
| Q3 24 | — | $85.9M | ||
| Q2 24 | — | $-6.2M | ||
| Q1 24 | — | $-4.6M |
| Q4 25 | — | 18.1% | ||
| Q3 25 | 54.1% | 10.7% | ||
| Q2 25 | 54.6% | -9.4% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | -14.9% | ||
| Q3 24 | — | 3.6% | ||
| Q2 24 | — | 9.1% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | — | -76.4% | ||
| Q3 25 | -226.7% | -111.4% | ||
| Q2 25 | -140.3% | -126.7% | ||
| Q1 25 | — | -103.8% | ||
| Q4 24 | — | -98.9% | ||
| Q3 24 | — | -146.2% | ||
| Q2 24 | — | -99.7% | ||
| Q1 24 | — | -76.0% |
| Q4 25 | — | -60.3% | ||
| Q3 25 | -223.9% | -68.9% | ||
| Q2 25 | -139.5% | -119.9% | ||
| Q1 25 | — | -90.9% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | — | 1315.8% | ||
| Q2 24 | — | -92.2% | ||
| Q1 24 | — | -68.5% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $-0.17 | $-0.15 | ||
| Q2 25 | $-2.02 | $-0.26 | ||
| Q1 25 | — | $-0.21 | ||
| Q4 24 | — | $0.00 | ||
| Q3 24 | — | $3.62 | ||
| Q2 24 | — | $-0.27 | ||
| Q1 24 | — | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $128.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $20.4M | $140.7M |
| Total Assets | $25.7M | $151.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $128.6M | ||
| Q3 25 | — | $126.3M | ||
| Q2 25 | — | $129.3M | ||
| Q1 25 | — | $132.4M | ||
| Q4 24 | — | $135.6M | ||
| Q3 24 | — | $145.4M | ||
| Q2 24 | — | $18.4M | ||
| Q1 24 | — | $21.6M |
| Q4 25 | — | $140.7M | ||
| Q3 25 | $20.4M | $143.7M | ||
| Q2 25 | $-139.0M | $146.4M | ||
| Q1 25 | — | $150.5M | ||
| Q4 24 | — | $154.1M | ||
| Q3 24 | — | $156.7M | ||
| Q2 24 | — | $65.1M | ||
| Q1 24 | — | $70.2M |
| Q4 25 | — | $151.3M | ||
| Q3 25 | $25.7M | $151.0M | ||
| Q2 25 | $9.5M | $153.9M | ||
| Q1 25 | — | $158.7M | ||
| Q4 24 | — | $163.2M | ||
| Q3 24 | — | $177.0M | ||
| Q2 24 | — | $97.8M | ||
| Q1 24 | — | $101.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.7M | $3.0M |
| Free Cash FlowOCF − Capex | $-5.7M | $2.8M |
| FCF MarginFCF / Revenue | -160.5% | 45.8% |
| Capex IntensityCapex / Revenue | 0.3% | 3.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-7.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.0M | ||
| Q3 25 | $-5.7M | $-2.9M | ||
| Q2 25 | $-9.5M | $-3.6M | ||
| Q1 25 | — | $-3.3M | ||
| Q4 24 | — | $-5.9M | ||
| Q3 24 | — | $-7.2M | ||
| Q2 24 | — | $-993.0K | ||
| Q1 24 | — | $-1.3M |
| Q4 25 | — | $2.8M | ||
| Q3 25 | $-5.7M | $-3.2M | ||
| Q2 25 | $-9.6M | $-3.8M | ||
| Q1 25 | — | $-3.6M | ||
| Q4 24 | — | $-6.5M | ||
| Q3 24 | — | $-7.7M | ||
| Q2 24 | — | $-1.1M | ||
| Q1 24 | — | $-1.5M |
| Q4 25 | — | 45.8% | ||
| Q3 25 | -160.5% | -64.5% | ||
| Q2 25 | -289.0% | -75.8% | ||
| Q1 25 | — | -68.0% | ||
| Q4 24 | — | -97.7% | ||
| Q3 24 | — | -118.2% | ||
| Q2 24 | — | -16.7% | ||
| Q1 24 | — | -23.0% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | 0.3% | 7.0% | ||
| Q2 25 | 2.1% | 5.0% | ||
| Q1 25 | — | 5.7% | ||
| Q4 24 | — | 9.3% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 3.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.08× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CV
| Products | $2.5M | 71% |
| Other | $1.0M | 29% |
INVE
| Other | $3.4M | 55% |
| Europe And Middle East | $2.2M | 36% |
| Asia Pacific | $575.0K | 9% |
